Cardio Diagnostics Holdings (CDIO) Shares Outstanding (2021 - 2026)

Cardio Diagnostics Holdings has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $3.0 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 70.21% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (up 70.21% YoY) and the FY2025 annual result came in at $1.8 million, up 103.72% from the prior year.
• Shares Outstanding (Entity) climbed to $3.0 million in Q1 2026 per CDIO's latest filing, from $1.8 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $3.0 million in Q1 2026 and troughed at $102912.0 in Q4 2022.
• A 5-year average of $914466.4 and a median of $720894.0 in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) surged 319.35% in 2022, then soared 47.94% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $102912.0 in 2022, then soared by 310.83% to $422795.0 in 2023, then surged by 112.0% to $896334.0 in 2024, then surged by 103.72% to $1.8 million in 2025, then soared by 62.07% to $3.0 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $3.0 million, $1.8 million, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.